Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Sweta Rani"'
Autor:
HIMALAYA BHARDWAJ, MUNNA KUMAR, SATYA P YADAV, SWETA RANI, AJEET KUMAR, AMRITA BEHERA, RAMESH TIWARY, SANJAY KUMAR, GYAN D SINGH
Publikováno v:
Indian Journal of Animal Sciences, Vol 94, Iss 10 (2024)
This retrospective study investigates the prevalence and epidemiological factors associated with renal insufficiency in dogs within Patna, Bihar, India. Out of 5,700 dogs with various illnesses, 317 were diagnosed with renal insufficiency, identified
Externí odkaz:
https://doaj.org/article/29265609ebaa441682694bb46e65b016
Autor:
Claire Corcoran, Sweta Rani, Susan Breslin, Martina Gogarty, Irene M Ghobrial, John Crown, Lorraine O’Driscoll
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/bac0adf778b6420686bb18b3b8779958
Autor:
Madhuri Dandamudi, Peter McLoughlin, Gautam Behl, Lee Coffey, Anuj Chauhan, David Kent, Sweta Rani, Laurence Fitzhenry
Publikováno v:
Frontiers in Drug Delivery, Vol 4 (2024)
Age-related macular degeneration (AMD) is a multifactorial degenerative disease characterised by the gradual loss of central vision in individuals aged more than 50 years. There is currently no cure for this disease, but treatment can delay its progr
Externí odkaz:
https://doaj.org/article/fab19845b047493b8b208479b236884d
Autor:
Thanh Hoa Vo, Esam EL-Sherbieny Abdelaal, Emmet Jordan, Orla O'Donovan, Edel A. McNeela, Jai Prakash Mehta, Sweta Rani
Publikováno v:
Biochemistry and Biophysics Reports, Vol 37, Iss , Pp 101588- (2024)
Breast cancer is the most common type of lethal cancer in women globally. Women have a 1 in 8 chance of developing breast cancer in their lifetime. Among the four primary molecular subtypes (luminal A, luminal B, HER2+, and triple-negative), HER2+ ac
Externí odkaz:
https://doaj.org/article/f9e0922ebe34466f9119b0ac537bd412
Autor:
Arun Jaiswal, Chandresh Kumar Rastogi, Sweta Rani, Gaurav Pratap Singh, Sumit Saxena, Shobha Shukla
Publikováno v:
iScience, Vol 26, Iss 4, Pp 106374- (2023)
Summary: Two-photon lithography (TPL) is a versatile technology for additive manufacturing of 2D and 3D micro/nanostructures with sub-wavelength resolved features. Recent advancement in laser technology has enabled the application of TPL fabricated s
Externí odkaz:
https://doaj.org/article/6719208ca72f432c8bd4dc49072f3ec4
Autor:
Sreeraj Kuruppilakath Manikandan, Ann Logan, Marc Cerrada-Gimenez, Laurence Fitzhenry, Lee Coffey, Simon Kaja, Sweta Rani
Publikováno v:
Life, Vol 13, Iss 12, p 2236 (2023)
Wet age-related macular degeneration (wAMD) is a chronic inflammation-associated neurodegenerative disease affecting the posterior part of the eye in the aging population. Aging results in the reduced functionality of cells and tissues, including the
Externí odkaz:
https://doaj.org/article/5ccf5828ec4b4f4185b20fd22c98209d
Publikováno v:
In Materials Today: Proceedings 2021 41 Part 2:357-362
Publikováno v:
ECS Advances, Vol 2, Iss 2, p 021001 (2023)
One of the simplest, most popular, and productive ways to conduct research and testing in the field of materials science is through the use of metallographic study. Technological boon in the field of metallographic study, opens new gateway for materi
Externí odkaz:
https://doaj.org/article/668da7f6c095424291feb01bd54a9680
Autor:
Arun Jaiswal, Sweta Rani, Gaurav Pratap Singh, T. Archana, Mahbub Hassan, Aklima Nasrin, Vincent G. Gomes, Sumit Saxena, Shobha Shukla
Publikováno v:
Carbon. 208:43-49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08ac0c5f8939e1bd5adbd96b4051dd5a
https://doi.org/10.1016/j.carbon.2023.03.049
https://doi.org/10.1016/j.carbon.2023.03.049
Autor:
Alex J Eustace, Neil T Conlon, Martina S J McDermott, Brigid C Browne, Patrick O’Leary, Frankie A Holmes, Virginia Espina, Lance A Liotta, Joyce O’Shaughnessy, Clair Gallagher, Lorraine O’Driscoll, Sweta Rani, Stephen F Madden, Neil A O’Brien, Charles Ginther, Dennis Slamon, Naomi Walsh, William M Gallagher, Radoslaw Zagozdzon, William R Watson, Norma O’Donovan, John Crown
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background Lapatinib has clinical efficacy in the treatment of trastuzumab-refractory HER2-positive breast cancer. However, a significant proportion of patients develop progressive disease due to acquired resistance to the drug. Induction of
Externí odkaz:
https://doaj.org/article/5de7181f330d45b98eeaa2bf7e64c819